ConductScience.org, home

Paper24670080

Rituximab (Rituxan) therapy for severe thyroid-associated ophthalmopathy diminishes IGF-1R(+) T cells.

McCoy AN and 5 others. J Clin Endocrinol Metab, 2014. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Rituximab (Rituxan) therapy for severe thyroid-associated ophthalmopathy diminishes IGF-1R(+) T cells. Papers, record 24670080. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24670080

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rituximab (Rituxan) therapy for severe thyroid-associated ophthalmopathy diminishes IGF-1R(+) T cells.
PubMed
Journal
J Clin Endocrinol Metab
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
0.94
iCite
Revised in PubMed
2022-03-17
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McCoy ANAllison N
2Kim DSDenise S
3Gillespie EFErin F
4Atkins SJStephen J
5Smith TJTerry J
6Douglas RSRaymond S

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, Monoclonal, Murine-DerivedMajor topic
Graves OphthalmopathyMajor topic
Receptor, IGF Type 1Major topic
T-LymphocytesMajor topic
Aged
Dose-Response Relationship, Drug
Female
Humans
Lymphocyte Count
Male
Middle Aged
Retrospective Studies
Rituximab
Severity of Illness Index
Treatment Outcome

Source PubMed

Download CSV of topics

Grants11

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 EY021197NEI NIH HHSUnited StatesR01EY021197PubMed and NIHNIH RePORTER
EY007003NEI NIH HHSUnited StatesPubMedPubMed
EY021197NEI NIH HHSUnited StatesR01EY021197PubMed and NIHNIH RePORTER
R01 EY011708NEI NIH HHSUnited StatesR01EY011708PubMed and NIHNIH RePORTER
EY011708NEI NIH HHSUnited StatesR01EY011708PubMed and NIHNIH RePORTER
P30 EY007003NEI NIH HHSUnited StatesP30EY007003PubMedNIH RePORTER
EY008976NEI NIH HHSUnited StatesR01EY008976PubMed and NIHNIH RePORTER
R01 DK063121NIDDK NIH HHSUnited StatesR01DK063121PubMed and NIHNIH RePORTER
R01 EY008976NEI NIH HHSUnited StatesR01EY008976PubMed and NIHNIH RePORTER
F31 EY007003NEI NIH HHSUnited StatesF31EY007003PubMedNIH RePORTER
DK063121NIDDK NIH HHSUnited StatesR01DK063121PubMed and NIHNIH RePORTER

Download CSV of grants

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112794168Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway.J Immunol2003https://conductscience.org/library/papers/12794168PubMed
221677036Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors?J Clin Endocrinol Metab2011https://conductscience.org/library/papers/21677036PubMed
317312178Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis.J Immunol2007https://conductscience.org/library/papers/17312178PubMed
414575864IGF-I stimulates IL-8 production in the promyelocytic cell line HL-60 through activation of extracellular signal-regulated protein kinase.Cell Signal2003https://conductscience.org/library/papers/14575864PubMed
517284622B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study.J Clin Endocrinol Metab2007https://conductscience.org/library/papers/17284622PubMed
618768899Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease.J Immunol2008https://conductscience.org/library/papers/18768899PubMed
715277570Insulin-like growth factor-I stimulates IL-10 production in human T cells.J Leukoc Biol2004https://conductscience.org/library/papers/15277570PubMed
819785644Evidence of orbital B and T cell depletion after rituximab therapy in Graves' ophthalmopathy.Acta Ophthalmol2009https://conductscience.org/library/papers/19785644PubMed
919818507Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy.Ophthalmology2010https://conductscience.org/library/papers/19818507PubMed
1018832736B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis.J Immunol2008https://conductscience.org/library/papers/18832736PubMed
118126135Effect of growth hormone and insulin-like growth factor-I on immunoglobulin production by and growth of human B cells.J Clin Endocrinol Metab1994https://conductscience.org/library/papers/8126135PubMed
1216914591Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers.Eur J Endocrinol2006https://conductscience.org/library/papers/16914591PubMed
138046348Growth hormone and insulin-like growth factor I induce immunoglobulin (Ig)E and IgG4 production by human B cells.J Exp Med1994https://conductscience.org/library/papers/8046348PubMed
1419897675Increased generation of fibrocytes in thyroid-associated ophthalmopathy.J Clin Endocrinol Metab2010https://conductscience.org/library/papers/19897675PubMed
1517822379The thyrotropin receptor in Graves' disease.Thyroid2007https://conductscience.org/library/papers/17822379PubMed
1617218723Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study.Eur J Endocrinol2007https://conductscience.org/library/papers/17218723PubMed
177517705Autoantibodies to IGF-1 binding sites in thyroid associated ophthalmopathy.Autoimmunity1993https://conductscience.org/library/papers/7517705PubMed
188306510Immunological effects of insulin-like growth factor-I--enhancement of immunoglobulin synthesis.Clin Exp Immunol1994https://conductscience.org/library/papers/8306510PubMed
1918085668Levels of autoantibodies, unlike antibodies to all extrinsic antigen groups, fall following B cell depletion with Rituximab.Eur J Immunol2008https://conductscience.org/library/papers/18085668PubMed
2020392809Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?Pharmacol Rev2010https://conductscience.org/library/papers/20392809PubMed

See all 25 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
41728592The therapeutic revolution in thyroid eye disease: from orbital radiotherapy to teprotumumab and AI.Front Med (Lausanne)2026https://conductscience.org/library/papers/41728592PubMed
41555141Elevated IGF1R and abnormal methylated IGF1R in immune thrombocytopenia.Ann Hematol2026https://conductscience.org/library/papers/41555141PubMed
40950996Hepatic tuberculosis induced by rituximab treatment for C1q nephropathy with minimal change disease: a case report.Front Med (Lausanne)2025https://conductscience.org/library/papers/40950996PubMed
40404973Comparative efficacy and safety of rituximab, tocilizumab, and teprotumumab in Graves' orbitopathy: a systematic review and meta-analysis.Eye (Lond)2025https://conductscience.org/library/papers/40404973PubMed
39039206Graves disease: latest understanding of pathogenesis and treatment options.Nat Rev Endocrinol2024https://conductscience.org/library/papers/39039206PubMed
38642306CD20 + T lymphocytes in isolated Hashimoto's thyroiditis and type 3 autoimmune polyendocrine syndrome: a pilot study.J Endocrinol Invest2024https://conductscience.org/library/papers/38642306PubMed
37108173Prostaglandin F2α Regulates Adipogenesis by Modulating Extracellular Signal-Regulated Kinase Signaling in Graves' Ophthalmopathy.Int J Mol Sci2023https://conductscience.org/library/papers/37108173PubMed
35604323Current concepts regarding Graves' orbitopathy.J Intern Med2022https://conductscience.org/library/papers/35604323PubMed
33868176Mechanisms That Underly T Cell Immunity in Graves' Orbitopathy.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/33868176PubMed
31919775Thyroid eye disease: current and potential medical management.Int Ophthalmol2020https://conductscience.org/library/papers/31919775PubMed
29736194Thyroid-Associated Orbitopathy and Biomarkers: Where We Are and What We Can Hope for the Future.Dis Markers2018https://conductscience.org/library/papers/29736194PubMed
29452583Does rituximab improve clinical outcomes of patients with thyroid-associated ophthalmopathy? A systematic review and meta-analysis.BMC Ophthalmol2018https://conductscience.org/library/papers/29452583PubMed
28702253Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surface.Clin Diabetes Endocrinol2016https://conductscience.org/library/papers/28702253PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
IGF1R3480PubTator's text mininghttps://conductscience.org/library/genes/3480NCBI Gene
KRT2054474PubTator's text mininghttps://conductscience.org/library/genes/54474NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24670080

GET https://conductscience.org/api/papers/v1/24670080/references?page=2